Effect of copper on the accumulation and elimination kinetics of fluoroquinolones in the zebrafish (Danio rerio)

Ecotoxicol Environ Saf. 2018 Jul 30:156:135-140. doi: 10.1016/j.ecoenv.2018.03.025. Epub 2018 Mar 20.

Abstract

Fluoroquinolones (FQs) have attracted wide concerns due to their pseudo-persistent and universal presence in natural water. Here we exposed zebrafish separately to two FQs (enrofloxacin (ENR) and ofloxacin (OFL)) in different copper (Cu) concentrations for 20 days (d) in a flow-through system, followed by a 11 d depuration period in clean water to investigate compound specific bioaccumulation and tissue distribution. Two FQs could accumulate in zebrafish, and the high concentration was observed in liver. Moreover, the levels of FQs in different treatment groups were higher than the corresponding control fish group. The uptake rates (k1), elimination rates (k2), BCF value, and half-lives (t1/2) of FQs ranged from 0.02 to 3.28 d-1, 0.01 to 0.97 d-1, 0.33 to 109.33, 9.90 to 69.31 d, respectively. With Cu exposure concentration's increasing, k1 values in three tissues (liver, skin and gill) obviously decreased. The exposure concentration affected the BCF value significantly, but didn't change their relative compositions in liver, gill, skin, and muscle after long time exposure. BCF values of ENR were always a little bit higher than those of OFL in almost all the tissues (liver, skin and gill) in the low Cu concentration treatments, whereas, in the high Cu concentration treatments the bioconcentration factors (BCF) values of ENR were lower than the values of OFL. The exposure of Cu played an important role in the FQs bioconcentration and BCF. These results are meaningful for improved understanding and prediction of the behavior and fate of metallic and antibiotics in aqueous environments.

Keywords: BCF; Bioconcentration; Distribution; FQs; Zebrafish.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacokinetics
  • Copper / toxicity*
  • Dose-Response Relationship, Drug
  • Enrofloxacin
  • Fluoroquinolones / pharmacokinetics*
  • Gills / drug effects
  • Gills / metabolism
  • Liver / drug effects
  • Liver / metabolism
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Ofloxacin / pharmacokinetics
  • Skin / drug effects
  • Skin / metabolism
  • Tissue Distribution
  • Zebrafish*

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Enrofloxacin
  • Copper
  • Ofloxacin